Amyloid beta catabody

N/A

Report date: 2025/01/26 17:12:55

Base Information

Drug NameAmyloid beta catabody
Drug Alias NameAmyloid beta catalytic antibody (AB Studio)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionBeta amyloid A4 protein modulators
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAb Studio Inc
China Registration ClassN/A

Develop Information

Active CompaniesAb Studio Inc
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A